Clinical Trial Update: Impact of Genetic Counseling for Individuals With Mental Illness [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluating the impact of genetic counseling in individuals with schizophrenia, bipolar disorder, and schizoaffective disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizoaffective Disorder
• Schizophrenia

Snippet

Sponsor: University of British Columbia | Conditions: Schizophrenia, Bipolar Disorder | Phase 3 | Status: COMPLETED